NCT03442569 2025-07-01PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRCUNC Lineberger Comprehensive Cancer CenterPhase 2 Completed56 enrolled 13 charts
NCT01769222 2024-01-24Ipilimumab and Local Radiation for Selected Solid TumorsStanford UniversityPhase 1 Terminated3 enrolled 5 charts